Atlas Trials

Keratinocyte Growth Factor to Prevent Acute GVHD

Clinical trial NCT00031148 · COMPLETED

Trial details

NCT number
NCT00031148
Sponsor
FDA Office of Orphan Products Development
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Graft-vs-Host Disease
Start date
2001-09-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.